Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts
Marco Roffi(University of Geneva), Eric J. Topol(Scripps Research Institute), Deepak L. Bhatt(Mount Sinai Hospital), Derek P. Chew, Leslie Cho(Cleveland Clinic), Stephen G. Ellis(Université de Perpignan), Danielle M. Brennan(Center for Clinical Research (United States)), Debabrata Mukherjee(Texas Tech University), Mark Robbins, Khaled M. Ziada(Cleveland Clinic)
Cited by 216
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Long COVID: major findings, mechanisms and recommendations
|Nature Reviews Microbiology|2023|4k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k